Online Enquiry
Subscribe
Log in / New User
Retrieve Password
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Log In
|
New User Registration
|
Retrieve Password
Log In
News
TheMarket
IndustryNews
RegulatoryNews
GeneralHealth
Legal/IPRNews
Product/R&DNews
API/BulkDrugNews
PeopleintheNews
OtherNews
TopNewsWorldwide
FEATURE ARTICLES
Editorials
FocusArticles
ExpertOpinions
Interviews
CaseStudies
CompanyProfiles
NewsinFocus
Editor'sPicks
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
NHSA Seeks Comments on 2026 NRDL and Commercial Innovation Drug List Adjustmen...
The NHSA has released draft proposals for the 2026 adjustment of the NRDL, as well as the Commercial Health Insurance Innovation Drug List, for public consultation before...
(5/11/2026)
Pharma CEOs Missing From Trump's China Delegat... (5/14/2026)
Life Sciences a "Sweet Spot" for U.S.-China Co... (5/14/2026)
China Emerges as Global Hub for siRNA Out-Lice... (5/11/2026)
A Strategic Playbook for Chinese Biotech Cross... (5/5/2026)
A Biopharmaceutical Superpower: China's Rise, ... (5/1/2026)
China Partnerships Drive Biopharma Deal Surge ... (4/29/2026)
From fast follower to originator: How Asia is ... (4/29/2026)
China Imposes Four-Year Deadline on Conditiona... (4/28/2026)
China Biopharma Financing Rebounds in March as... (4/27/2026)
China Biopharma Deal Activity Slows in Q1 2026... (4/22/2026)
China's Push to Elevate Private Health Insuran... (4/22/2026)
Chinese Biotech Commands One-Third of Global P... (4/21/2026)
Recent Executive Moves (5/15/2026)
Kovyi Pharma Raises Pre-A Round for Neur... (5/15/2026)
Yirui Pharma Raises CNY 100Ms A++ Round ... (5/15/2026)
CDE Issues New TCM Post-Approval Change ... (5/15/2026)
CDE Issues Revised Review Guideline for ... (5/15/2026)
CDE Releases Revised Review Guideline fo... (5/15/2026)
CDE Releases Operational Procedures for ... (5/15/2026)
CDE Issues Filing Requirements for Drug ... (5/15/2026)
China Introduces Drug Trial Data Protect... (5/15/2026)
Major Study Warns Neurological Diseases ... (5/15/2026)
Rehydration Raises Angel+ Financing to A... (5/15/2026)
Degron and Merck Expand Partnership to A... (5/15/2026)
Degron Extends Series A to $95M as Molec... (5/15/2026)
PepLib Raises Over CNY 300M in Series C ... (5/15/2026)
BeOne's Sonrotoclax Wins FDA Accelerated... (5/15/2026)
China Launches Five-Year Crackdown Plan ... (5/14/2026)
China Expands Regional Healthcare Influe... (5/14/2026)
Kelun-Biotech Secures China IND Clearanc... (5/14/2026)
China Pharma Market Set for Structural Shift as Innovat...
China Pharmaceutical Market Projected to Reach US$573B ...
China's Vaccine Exports Jump More Than 50% in 2025 as O...
China's Vaccine Market Set for Slow but Steady Growth T...
China Companion Animal Health Market to Reach US$ 3.7B ...
PepLib Raises Over CNY 300M in Series C Financing
Degron Extends Series A to $95M as Molecular Glue Platf...
Degron and Merck Expand Partnership to Advance Molecula...
Rehydration Raises Angel+ Financing to Advance Oligonuc...
Yirui Pharma Raises CNY 100Ms A++ Round to Advance Auto...
China Introduces Drug Trial Data Protection Rules to St...
CDE Issues Filing Requirements for Drug Data Protection...
CDE Releases Operational Procedures for Drug Trial Data...
CDE Releases Revised Review Guideline for Chemical Drug...
CDE Issues Revised Review Guideline for Biologics Chang...
Major Study Warns Neurological Diseases Are Surging Acr...
China Launches Five-Year Crackdown Plan to Strengthen O...
Study Finds Over 60% of Chinese Outpatients With Abnorm...
China Holds National Healthcare Reform Meeting, Priorit...
China Expands National Pediatric Medical Center Network...
China Tightens Biopharma Supply Chain Controls, Raising...
U.S. Lawmakers Push to Bar China Clinical Data From FDA...
Bayer Secures Nearly Five-Year China Patent Extension f...
U.S. ITC to Probe China's Trade Status and Biotech Prac...
China Schedules Antitrust Hearing in Abuse‑of‑Dominan...
Chinese API Makers Raise Prices as Middle East Conflict...
India Still Relies Heavily on China for Essential Pharm...
Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See...
Abraham Accords Partners Could Help the U.S. Reduce Pha...
PhIIC Report Highlights China's API Industry Rebound as...
BeOne's Sonrotoclax Wins FDA Accelerated Approval for M...
Hansoh Advances EGFR Pipeline as HS-10541 Wins Clinical...
Chinese Researchers Explore Mosquito-Delivered "Flying ...
Sinocelltech Advances Dual Trispecific Antibody Combo I...
BeOne Culls Multiple Early Oncology Programs, Halts Pha...
BioAtla and BeiGene Revise Global Deal for Novel Condit...
Pfizer to Absorb Mylan, Creating Global Generic Powerho...
PhRMA Calls for Trade Deals That Force Countries to Pay...
IQVIA: Global Pharma to Grow Slower in the Next Five Ye...
Pfizer and GSK Announce JV to Create a Global Consumer ...
Recent Executive Moves
Recent Executive Moves
Recent Official and Executive Moves
Former NMPA Deputy Commissioner Sentenced to 14 Years f...
Former Jiangxi Provincial Health Commission Chief Dismi...
China Introduces Plan for Pudong New Area's Pilot Compr...
Upcoming Event: 2023 Pharma CI USA Conference & Exhibit...
Upcoming Event: 15th Annual Pharma Market Research Conf...
Upcoming Event: 6th International Conference on Emergin...
Upcoming Event: PHARM Connect Congress
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
2023 Order Form + Product Descripti...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WEEKLY e-ALERT(Premium)
WEEKLY e-ALERT(Basic)
GENERAL INFORMATION
TERMS/CONDITIONS OF USE
PRIVACY STATEMENT
JOIN THE MAILING LIST
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit